文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症相关凝血病严重程度预测院内死亡率

Sepsis-Associated Coagulopathy Severity Predicts Hospital Mortality.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论脓毒症相关凝血病的存在及严重程度与院内死亡率独立相关,死亡率从无凝血病的25.4%升至重度凝血病的56.1%。

这项回顾性队列研究纳入2010年1月1日至2015年12月31日期间在一家1300张床位的城市学术医疗中心连续住院的6148例患者,评估脓毒症相关凝血病是否预测院内死亡率。凝血病按国际标准化比值和血小板计数分为轻度、中度和重度。院内死亡率从无凝血病患者的25.4%逐步升高至重度凝血病患者的56.1%,住院时间和ICU治疗时间也随严重程度增加而延长。多变量分析显示,凝血病的存在及严重程度均与院内死亡率独立相关,校正基线特征、住院变量及凝血病-癌症交互作用后仍显著。

要点

  • 脓毒症相关凝血病的存在及严重程度与院内死亡率独立相关,比值比范围分别为1.33–2.14和1.18–1.51(所有比较P<0.001)。
  • 院内死亡率从无凝血病患者的25.4%逐步升高至重度凝血病患者的56.1%。
  • 住院时间和ICU治疗时间随脓毒症相关凝血病严重程度增加而逐步延长。
  • 脓毒症相关凝血病严重程度分级基于国际标准化比值和血小板计数:轻度为INR≥1.2且<1.4加血小板≤150,000/µL且>100,000/µL;中度为INR≥1.4且<1.6或血小板≤100,000/µL且>80,000/µL;重度为INR≥1.6且血小板≤80,000/µL。

适用人群与场景

  • 2010年1月1日至2015年12月31日期间在一家1300张床位的城市学术医疗中心连续住院的6148例患者。

诊断标准与关键阈值

  • 轻度脓毒症相关凝血病:国际标准化比值≥1.2且<1.4,加血小板计数≤150,000/µL且>100,000/µL。
  • 中度脓毒症相关凝血病:国际标准化比值≥1.4且<1.6,或血小板计数≤100,000/µL且>80,000/µL。
  • 重度脓毒症相关凝血病:国际标准化比值≥1.6且血小板计数≤80,000/µL。

研究设计与关键结果

  • 研究类型为回顾性队列研究,样本量6148例,人群为上述连续住院患者,干预与对照未设,主要终点为院内死亡率。
  • 院内死亡率从无脓毒症相关凝血病患者的25.4%逐步升高至重度脓毒症相关凝血病患者的56.1%。
  • 住院时间和ICU治疗时间随脓毒症相关凝血病严重程度增加而逐步延长。
  • 多变量分析显示,脓毒症相关凝血病的存在及严重程度均与院内死亡率独立相关,校正基线患者特征、住院变量及脓毒症相关凝血病-癌症交互作用后仍显著。
  • 脓毒症相关凝血病的存在预测院内死亡率的比值比为1.33–2.14,严重程度预测院内死亡率的比值比为1.18–1.51(所有比较P<0.001)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,脓毒症相关凝血病的存在识别出死亡风险较高的脓毒症患者群体,且随着脓毒症相关凝血病严重程度增加,死亡风险呈递增趋势。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To assess whether sepsis-associated coagulopathy predicts hospital mortality.

DESIGN: Retrospective cohort study.

SETTING: One-thousand three-hundred beds urban academic medical center.

PATIENTS: Six-thousand one-hundred forty-eight consecutive patients hospitalized between January 1, 2010, and December 31, 2015.

INTERVENTIONS: Mild sepsis-associated coagulopathy was defined as an international normalized ratio greater than or equal to 1.2 and less than 1.4 plus platelet count less than or equal to 150,000/µL but greater than 100,000/µL; moderate sepsis-associated coagulopathy was defined with either an international normalized ratio greater than or equal to 1.4 but less than 1.6 or platelets less than or equal to 100,000/µL but greater than 80,000/µL; severe sepsis-associated coagulopathy was defined as an international normalized ratio greater than or equal to 1.6 and platelets less than or equal to 80,000/µL.

MEASUREMENTS AND MAIN RESULTS: Hospital mortality increased progressively from 25.4% in patients without sepsis-associated coagulopathy to 56.1% in patients with severe sepsis-associated coagulopathy. Similarly, duration of hospitalization and ICU care increased progressively as sepsis-associated coagulopathy severity increased. Multivariable analyses showed that the presence of sepsis-associated coagulopathy, as well as sepsis-associated coagulopathy severity, was independently associated with hospital mortality regardless of adjustments made for baseline patient characteristics, hospitalization variables, and the sepsis-associated coagulopathy-cancer interaction. Odds ratios ranged from 1.33 to 2.14 for the presence of sepsis-associated coagulopathy and from 1.18 to 1.51 for sepsis-associated coagulopathy severity for predicting hospital mortality (p < 0.001 for all comparisons).

CONCLUSIONS: The presence of sepsis-associated coagulopathy identifies a group of patients with sepsis at higher risk for mortality. Furthermore, there is an incremental risk of mortality as the severity of sepsis-associated coagulopathy increases.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Lyons PG, Micek ST, Hampton N, et al. Sepsis-Associated Coagulopathy Severity Predicts Hospital Mortality. Crit Care Med. 2018. PMID: 29373360. doi:10.1097/CCM.0000000000002997

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。